Previous Pause Next
Home >> News Center >>
Enfield targeted for new biopower plant PDF Print E-mail
User Rating :  / 0
Tuesday, 07 September 2010 17:29

Enfield, north London, UK, will soon be home to a new biomass plant after Enfield council granted planning permission on 31 August.

Irish-based Kedco, the renewable energy firm behind the plans, can now begin securing funding for the 12MW plant, which is predicted to cost in the region of £45 million (€53.6 million) to build. Following this, it is thought that the facility will be up and running within 18 months.

Donal Buckley, CEO of Kedco, said: ‘We believe that the biomass clean tech sector is currently at the same stage as the wind industry was five years ago. This represents an enormous opportunity for growth for Kedco.’

In addition to the 12MW of electricity the facility will generate each year, it will also produce 10MW of heat, all from 60,000 tonnes of waste wood obtained from the construction and demolition industries located within a five-mile radius of the proposed site.

‘We believe that the granting of this consent shows the commitment of the Greater London Authority and Enfield council to the biomass sector within London,’ commented Buckley.

 
FairExcellent 

Add comment  |   Add to my library  |  Forward this article

login to leave comment

Biomarkers & Drug Targets

Scripps research scientists elevate little-studied cellular mechanism to potential drug target

New advance announced in reducing 'bad' cholesterol

Proteins do not predict outcome of herceptin treatment in HER2-positive breast cancer

New gene study of ADHD points to defects in brain signaling pathways

Inhibitors of infamous Ras oncogene reported by Genentech researchers at ASCB annual meeting

SRI Researchers Validate Preclinical Effectiveness of Tuberculosis Drug Target that Could Shorten Treatment Time

New potential therapeutic target identified for Diffuse Large B-Cell Lymphoma

Vitamin D–fortified yoghurt improves cholesterol levels and heart disease biomarkers for diabetics

U-M researchers find genetic rearrangements driving 5 to 7 percent of breast cancers

Researchers discover genes involved in colorectal cancer

>> More in: Biomarkers & Drug Targets

Systems Bio & Personalized Med

New trial model unlocks power of personalized medicine

UPMC to Build $300M Center for 'Innovative' Biomedical Science

Manchester's 'first step' to perfect drug combinations

Good Start Genetics? Announces Validation Results For Its Next-Generation DNA Sequencing Platform For Genetic Disorder Carrier Screening

Young Genes Correlated With Evolution Of Human Brain

UGA Scientists Team Up To Define First-Ever Sequence Of Biologically Important Carbohydrate

Cells Are Crawling All Over Our Bodies, But How?

First-Ever Sequence and Structure of Biologically Important Carbohydrate

New Gene Therapy Methods Accurately Correct Mutation In Patient's Stem Cells, Bringing Personalized Cell Therapies One Step Closer

Cells Have Early-Warning System for Intruders

>> More in: Systems Bio & Personalized Med, Systems Bio & Personalized Med

Bio-Chip & Nanotechnology

Getting Cancer Cells to Swallow Poison: Nanotechnology Researchers Develop New Strategy to Deliver Chemotherapy to Prostate Cancer Cells

OU researchers target cancer with nanoparticles

UCLA physicists report nanotechnology feat with proteins

Lightning-fast, efficient data transmission developed at Stanford

A realistic look at the promises and perils of nanomedicine

Berkeley Lab Researchers Ink Nanostructures with Tiny ‘Soldering Iron’

Study indicates nanoparticles could help pain-relieving osteoarthritis drugs last longer

Mobile Electrons Multiplied in Quantum Dot Films

Could a Computer One Day Rewire Itself? New Nanomaterial 'Steers' Electric Currents in Multiple Dimensions

Nano Funnel Used to Generate Extreme Ultraviolet Light Pulses

>> More in: Bio-Chip & Nanotechnology

Biomedical Imaging

Penn engineers develop more effective MRI contrast agent for cancer detection

PET Technique Promises Better Detection and Therapy Response Assessment for a Deadly Form of Non-Hodgkin’s Lymphoma

A single cell endoscope

Yale researchers develop a way to monitor engineered blood vessels as they grow in patients

Integrated 3-D imaging facilitates human face transplantation

Combined arterial imaging technology reveals both structural and metabolic details

Cornell Reaches Two Milestones toward a New Coherent X-ray Source

Test Combination Helps Predict Alzheimer's Disease Risk

New Instrument Helps Researchers See How Diseases Start And Develop In Minute Detail

Trio of Studies Support Use of PET/CT Scans as Prostate Cancer Staging Tool

>> More in: Biomedical Imaging